Edition:
United States

SCYNEXIS Inc (SCYX.OQ)

SCYX.OQ on NASDAQ Stock Exchange Global Market

1.37USD
17 Aug 2018
Change (% chg)

$0.06 (+4.58%)
Prev Close
$1.31
Open
$1.32
Day's High
$1.37
Day's Low
$1.32
Volume
17,396
Avg. Vol
83,079
52-wk High
$2.50
52-wk Low
$1.05

Chart for

About

SCYNEXIS, Inc. is engaged in the discovery, development and commercialization of anti-infectives. The Company is developing its lead product candidate, SCY-078, as an oral and intravenous (IV) drug for the treatment of several fungal infections, including serious invasive fungal infections. SCY-078 is a structurally distinct... (more)

Overall

Beta: 0.43
Market Cap(Mil.): $64.18
Shares Outstanding(Mil.): 46.84
Dividend: --
Yield (%): --

Financials

  SCYX.OQ Industry Sector
P/E (TTM): -- 28.29 30.45
EPS (TTM): -0.90 -- --
ROI: -66.81 12.92 12.63
ROE: -105.66 14.94 14.82

BRIEF-Scynexis Q1 Loss Per Share $0.12

* SCYNEXIS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES COMPANY UPDATE

May 08 2018

BRIEF-Caxton Corporation Reports 9.99 Percent Passive Stake In Scynexis Inc As Of March 6, 2018 - SEC Filing‍​

* CAXTON CORPORATION REPORTS 9.99 PERCENT PASSIVE STAKE IN SCYNEXIS INC AS OF MARCH 6, 2018 - SEC FILING‍​ Source text (http://bit.ly/2tII9WD) Further company coverage: (Reuters.Brief@thomsonreuters.com)

Mar 13 2018

BRIEF-SCYNEXIS Announces Pricing Of $30 Mln Public Offering Of Common Stock And Warrants

* SCYNEXIS ANNOUNCES PRICING OF $30.0 MILLION PUBLIC OFFERING OF COMMON STOCK AND WARRANTS

Mar 06 2018

Earnings vs. Estimates